The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...

In a study published in Science, researchers have resolved, for the first time, the high-resolution crystal structure of the ...

Plant breeders have always faced a brutal trade-off: the traits that matter most for food security, like drought tolerance or ...

Proceeds to fund clinical development of DIAG723, a first-in-class, disease-modifying therapy designed to correct the root cause of hereditary hemorrhagic telangiectasia and pulmonary arterial ...

Technologies at the Advanced Rodent Transgenics Laboratory include genome editing design and implementation and transgenic ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...

Rowyn Grace, the daughter of Hewlett assistant boys basketball coach Jonathon Welsh, was diagnosed with a rare pediatric ...

Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited ...

RVMD stays a Strong Buy as RAS inhibitor trials advance; phase 3 RASolute-302 is a key 2026 catalyst. Read the latest ...

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young adults under the age of 50.

An analysis of genetic data from over 900,000 people shows that certain stretches of DNA, made up of short sequences repeated ...